These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 22272606)

  • 1. Cancers of unknown primary origin: current perspectives and future therapeutic strategies.
    Stella GM; Senetta R; Cassenti A; Ronco M; Cassoni P
    J Transl Med; 2012 Jan; 10():12. PubMed ID: 22272606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cancer of unknown primary site origin--advances in diagnosis and therapy].
    Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H
    Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and therapeutic management of cancer of an unknown primary.
    Pavlidis N; Briasoulis E; Hainsworth J; Greco FA
    Eur J Cancer; 2003 Sep; 39(14):1990-2005. PubMed ID: 12957453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of unknown primary cancer based on molecular techniques may influence therapeutic approach and improve survival.
    Homet B; Hitt R; Ghanem I; Cortés-Funes H
    Clin Transl Oncol; 2010 Aug; 12(8):574-5. PubMed ID: 20709655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid biopsy: a new diagnostic, predictive and prognostic window in cancers of unknown primary.
    El Rassy E; Khaled H; Pavlidis N
    Eur J Cancer; 2018 Dec; 105():28-32. PubMed ID: 30388661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoma of unknown primary (CUP): an update for histopathologists.
    Beauchamp K; Moran B; O'Brien T; Brennan D; Crown J; Sheahan K; Cotter MB
    Cancer Metastasis Rev; 2023 Dec; 42(4):1189-1200. PubMed ID: 37394540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma of unknown primary (CUP).
    Pavlidis N; Fizazi K
    Crit Rev Oncol Hematol; 2009 Mar; 69(3):271-8. PubMed ID: 18977667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer from an unknown primary site.
    Dowell JE
    Am J Med Sci; 2003 Jul; 326(1):35-46. PubMed ID: 12861124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review on Cancer of Unknown Primary Origin: The Role of Molecular Biomarkers in the Identification of Unknown Primary Origin.
    Yan N; Zhang Y; Guo X; Yuan D; Tian G; Yang J
    Methods Mol Biol; 2020; 2204():109-119. PubMed ID: 32710319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metastases of unknown origin--principles of diagnosis and treatment].
    Petrović D; Muzikravić L; Jovanović D
    Med Pregl; 2007; 60(1-2):29-36. PubMed ID: 17853708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Biology to Diagnosis and Treatment: The Ariadne's Thread in Cancer of Unknown Primary.
    Mathew BG; Aliyuda F; Taiwo D; Adekeye K; Agada G; Sanchez E; Ghose A; Rassy E; Boussios S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular diagnosis of the tissue of origin in cancer of unknown primary site: useful in patient management.
    Greco FA
    Curr Treat Options Oncol; 2013 Dec; 14(4):634-42. PubMed ID: 23990214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in refining the clinical management of cancer of unknown primary in the molecular era.
    Rassy E; Pavlidis N
    Nat Rev Clin Oncol; 2020 Sep; 17(9):541-554. PubMed ID: 32350398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unknown primary tumour--diagnostic strategies and treatment].
    Møller AK; Gundgaard MG; Petersen BL; Daugaard G
    Ugeskr Laeger; 2008 Nov; 170(48):3946-9. PubMed ID: 19087733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of various techniques/platforms with critical evaluation of each.
    Agwa E; Ma PC
    Curr Treat Options Oncol; 2013 Dec; 14(4):623-33. PubMed ID: 24243164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancers of unknown primary site: ESMO clinical recommendation for diagnosis, treatment and follow-up.
    Briasoulis E; Pavlidis N; Felip E;
    Ann Oncol; 2008 May; 19 Suppl 2():ii106-7. PubMed ID: 18456742
    [No Abstract]   [Full Text] [Related]  

  • 17. Unknown primary tumors.
    Natoli C; Ramazzotti V; Nappi O; Giacomini P; Palmeri S; Salvatore M; Landriscina M; Zilli M; Natali PG; Tinari N; Iacobelli S
    Biochim Biophys Acta; 2011 Aug; 1816(1):13-24. PubMed ID: 21371531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary.
    Losa F; Iglesias L; Pané M; Sanz J; Nieto B; Fusté V; de la Cruz-Merino L; Concha Á; Balañá C; Matías-Guiu X
    Clin Transl Oncol; 2018 Nov; 20(11):1361-1372. PubMed ID: 29808414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer of unknown primary site: 20 questions to be answered.
    Pavlidis N; Pentheroudakis G
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii303-7. PubMed ID: 20943633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancers of Unknown Primary: A Descriptive Study in the U.S. Military Health System.
    Bytnar JA; Lin J; Moncur JT; Shriver CD; Zhu K
    Mil Med; 2023 Mar; 188(3-4):e516-e523. PubMed ID: 34296267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.